Archit Organosys Ltd.

BSE: 524640 SECTOR: Chemicals  8966   26   5

66.49
+1.35 (2.07%)
BSE: Today, 09:30 AM

Price Summary

Today's High

₹ 66.49

Today's Low

₹ 66.49

52 Week High

₹ 100

52 Week Low

₹ 0

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

136.44 Cr.

Enterprise Value

163.21 Cr.

No. of Shares

2.05 Cr.

P/E

11.94

P/B

2.21

Face Value

₹ 10

Div. Yield

0.76 %

Book Value (TTM)

₹  30.14

CASH

5.35 Cr.

DEBT

32.12 Cr.

Promoter Holding

62.37 %

EPS (TTM)

₹  5.57

Sales Growth

44.6%

ROE

18.08 %

ROCE

17.97%

Profit Growth

64.42 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year44.6%
3 Year17.62%
5 Year23.26%

Profit Growth

1 Year64.42%
3 Year55.3%
5 Year36.89%

ROE%

1 Year18.08%
3 Year9.81%
5 Year3.66%

ROCE %

1 Year17.97%
3 Year10.97%
5 Year7.12%

Debt/Equity

0.619

Price to Cash Flow

12.85

Interest Cover Ratio

5.66838277355561

CFO/PAT (5 Yr. Avg.)

3.45648634198503

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2023 62.37 0
Dec 2022 61.64 0
Sep 2022 59.83 0
Jun 2022 57.4 0
Mar 2022 57.4 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 55.2989341143234% for the Past 3 years.
  • The company has shown a good revenue growth of 17.6154864660391% for the Past 3 years.
  • Company’s PEG ratio is 0.58670424921374.
  • The company has an efficient Cash Conversion Cycle of 28.0738317361563 days.
  • The company has a good cash flow management; CFO/PAT stands at 3.45648634198503.
  • The company has a high promoter holding of 62.37%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
Net Sales 26.29 30.35 28.46 22.42 46.55
Total Expenditure 21.86 23.18 23.23 18.84 43.63
Operating Profit 4.43 7.17 5.23 3.59 2.92
Other Income 0.42 0.21 0.17 0.19 1.35
Interest 0.67 0.86 0.32 0.52 0.51
Depreciation 1.23 1.2 1.17 1.31 1.16
Exceptional Items 0 0 0 1.65 0
Profit Before Tax 2.96 5.33 3.91 3.6 2.6
Tax 1.08 1.21 0.85 1.36 0.59
Profit After Tax 1.88 4.12 3.06 2.24 2.01
Adjusted EPS (Rs) 0.91 2.01 1.49 1.09 0.98

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 81.54 84 76.69 94.51 136.66
Total Expenditure 77.59 87 73.12 83.45 120.6
Operating Profit 3.95 -3 3.57 11.06 16.06
Other Income 2.85 3.14 2.29 0.54 2.5
Interest 3.83 3.61 3.17 3.25 2.45
Depreciation 2.59 2.79 3.47 3.67 4.69
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.38 -6.26 -0.79 4.68 11.43
Tax -0.12 -1.54 0.01 -0.32 3.19
Net Profit 0.51 -4.72 -0.8 5.01 8.23
Adjusted EPS (Rs.) 0.34 -3.14 -0.53 3.33 4.01

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 15.04 15.02 15.02 15.02 20.52
Total Reserves 24.55 19.9 19.09 25.52 31.37
Borrowings 19.23 17.78 12.4 12.11 12.21
Other N/C liabilities 1.71 -0.49 0.45 -0.82 1.85
Current liabilities 42.21 32.68 35.66 34.58 39.44
Total Liabilities 102.74 84.89 82.61 86.41 105.39
Assets
Net Block 47.38 47.02 50.42 47.67 45.05
Capital WIP 7.67 4.85 1.08 2.98 12.75
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0.3 1.4
Loans & Advances 1.94 0.78 0.76 0.99 1.43
Other N/C Assets 0 0 0 0 0
Current Assets 45.75 32.25 30.36 34.47 44.76
Total Assets 102.74 84.89 82.61 86.41 105.39
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 0.38 -6.26 -0.79 4.68 11.43
Adjustment 5.88 5.84 6.08 7.5 6.36
Changes in Assets & Liabilities -9.66 3.35 2.53 -1.05 -5.7
Tax Paid -0.38 -0.19 -0.08 -0.02 -1.47
Operating Cash Flow -3.77 2.75 7.74 11.11 10.62
Investing Cash Flow -9.41 1.06 -0.82 -2.87 -11.52
Financing Cash Flow 13.37 0.36 -8.87 -7.38 2.43
Net Cash Flow 0.19 4.16 -1.95 0.86 1.54

Corporate Actions

Investors Details

PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Promoters 57.40 57.40 59.83 61.64 62.37
kandarp krishnakan... 17.89 17.89 17.89 17.89 17.89
archana kandarp am... 18.86 18.86 18.86 18.86 18.86
archit kandarp amin 7.90 7.90 7.90 7.90 7.90
suchit kandarp amin 7.88 7.88 7.88 7.88 7.88
manini suchit amin 2.44 2.44 2.44 - 2.44
shimoli archit amin 2.44 2.44 2.44 - 2.44
manini amin - - - 2.44 -
shimoli amin - - - 2.44 -
PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Investors 42.60 42.60 40.17 38.36 37.63
patel sanjaykumar... - - - - -
viraj samirbhai sh... 4.87 4.87 4.87 4.87 4.87
amoli samir shah 4.87 4.87 4.87 4.87 4.87
mansi munjal patel - - - - -
munjal mahendrabha... - - - - -
sagar samir shah - - - - -
bhavana ankala - - - - -
dheeraj kumar lohia - - - 1.08 1.06
standard greases a... - - - 1.16 -
llp 0.28 0.19 - 0.05 0.28

Annual Reports

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Archit Organosys - Quaterly Results12 May 2023, 11:50PM Archit Organosys - Quaterly Results12 May 2023, 11:50PM Archit Organosys informs about board meeting3 May 2023, 12:23PM Archit Organosys informs about non-applicability of large corporate entity28 Apr 2023, 2:01PM Archit Organosys informs about disclosure 6 Mar 2023, 9:43AM Archit Organosys informs about disclosure4 Mar 2023, 4:00PM Archit Organosys informs about disclosure25 Feb 2023, 11:26AM Archit Organosys informs about disclosure 4 Feb 2023, 10:43AM Archit Organosys - Quaterly Results13 Jan 2023, 7:48PM Archit Organosys - Quaterly Results13 Jan 2023, 7:48PM Archit Organosys informs about loss of share certificates29 Dec 2022, 4:20PM Archit Organosys informs about disclosure16 Sep 2022, 12:02PM Archit Organosys incorporates Wholly Owned Subsidiary3 Sep 2022, 9:24AM Archit Organosys informs about disclosure 30 Aug 2022, 4:21PM Archit Organosys informs about disclosure 26 Aug 2022, 10:14AM Archit Organosys informs about disclosure30 Jul 2022, 11:08AM Archit Organosys informs about disclosure26 Jul 2022, 5:02PM Archit Organosys gets nod to incorporate new wholly owned subsidiary 26 Jul 2022, 11:18AM Archit Organosys - Quaterly Results25 Jul 2022, 5:45PM Archit Organosys - Quaterly Results25 Jul 2022, 5:45PM Archit Organosys - Quaterly Results12 May 2022, 7:14PM Archit Organosys - Quaterly Results12 May 2022, 7:14PM Archit Organosys informs about loss of share certificates21 Jan 2022, 3:25PM Archit Organosys informs about loss of share certificates9 Dec 2021, 4:14PM Archit Organosys informs about loss of share certificates26 Nov 2021, 2:55PM Archit Organosys gets nod to expand existing production capacity22 Sep 2021, 9:44AM Archit Organosys informs about newspaper publication25 Aug 2021, 4:40PM Archit Organosys informs about disclosure14 Jun 2021, 4:30PM Archit Organosys informs about disclosure1 Jun 2021, 4:37PM Archit Organosys informs about loss of certificate21 Apr 2021, 3:25PM Archit Organosys informs about annual report7 Sep 2020, 3:38PM

Archit Organosys Stock Price Analysis and Quick Research Report. Is Archit Organosys an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a LOW P/E are undervalued (it depends on other factors too). Archit Organosys has a PE ratio of 11.697943790967 which is low and comparatively undervalued .

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Archit Organosys has ROA of 8.58385121018683 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Archit Organosys has a Current ratio of 1.13497915673527 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Archit Organosys has a ROE of 18.0803022315937 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Archit Organosys has a D/E ratio of 0.619 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Archit Organosys has an Inventory turnover ratio of 28.8421496934587 which shows that the management is efficient in relation to its Inventory and working capital management.

  • Sales growth: - Archit Organosys has reported revenue growth of 44.6010631544198 % which is fair in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Archit Organosys for the current financial year is 11.7539926330378 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Archit Organosys is Rs 0.75 and the yield is 0.7704 %.

Brief about Archit Organosys

X